National Drug Schedules

NOTE - Effective December 19, 2013, Schedule F to the Food and Drug Regulationswas repealed and replaced by a list of prescription drugs, called the Prescription Drug List. Therefore, all entries in the National Drug Schedules (NDS) whose footnote indicates that they appear in Schedule F (F1/F2) should now be considered part of the Prescription Drug List (PDL).

Entries whose footnote indicates that they are "Schedule F Recommended" (FR) should now be considered recommended for addition to the PDL. Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS.

For more information on the Prescription Drug List, please consult the Health Canada website.

Drug Product Database
Licensed Natural Health Products Database

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Haemophilus influenzae type B vaccine		II	DEC / 98
Halofantrine or its salts		I	DEC / 13
Halofuginone or its salts	For veterinary use.	I	MAY / 18
Haloperidol		I	DEC / 13
Haloprogin		III	SEP / 98
Halothane		I	DEC / 13
Hemin		I	AUG / 18
Heparin and its salts.	except for topical use	II	SEP / 99
Hepatitis A vaccine		I	FEB / 02
Hepatitis B Adult vaccine		I	FEB / 02
Hepatitis B Pediatric vaccine		II	DEC / 98
Hepatitis B immune globulin		I	FEB / 02
Hetacillin or its salts or derivatives	For veterinary use.	I	DEC / 13
Hetastarch or its derivatives		I	DEC / 13
Hexachlorophene or its salts		I	DEC / 13
Hexacyclonate sodium		I	DEC / 13
Hexamethonium or its salts		I	DEC / 13
Histamine and its salts	except for topical use	II	SEP / 98
Histrelin or its salts		I	DEC / 13
Homatropine and its salts	for oral use in concentrations of 2 mg or less per dosage unit	II	SEP / 98
Homatropine and its salts	for ophthalmic or parenteral use or in preparations for oral use containing more than 2 mg per dosage unit	I	SEP / 98
Human insulin		II	SEP / 98
Hyaluronic acid and its salts	preparations in concentrations of 5% or more	II	SEP / 98
Hyaluronic acid or its salts	For veterinary use - when sold or recommended for administration by intra-articular injection to horses.	I	DEC / 13
Hyaluronidase		II	SEP / 98
Hydralazine or its salts		I	DEC / 13
Hydrocortisone aceponate	For veterinary use.	I	DEC / 13
Hydrocortisone or hydrocortisone acetate	When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in children under 2 years of age.	I	DEC / 14
Hydrocortisone or hydrocortisone acetate.	When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in adults and children 2 years of age and over in package sizes containing more than 30 g.	I	DEC / 14
Hydroquinone or its derivatives	When sold in a concentration less than or equal to 2% in preparations for topical use on the skin	II	JUN / 19
Hydroquinone or its derivatives	When sold in a concentration greater than 2% in preparations for topical use on the skin.	I	JUN / 19
Hydroxocobalamin or its salts	When recommended as an antidote for cyanide poisoning.	I	DEC / 13
Hydroxychloroquine or its salts		I	DEC / 13
4- Hydroxycoumarin or its derivatives	Including but not limited to acenocoumarol when sold or recommended as anticoagulants.	I	DEC / 13
Hydroxyephedrine and its salts		II	SEP / 98
Hydroxyurea		I	DEC / 13
Hydroxyzine or its salts or derivatives	Including but not limited to cetirizine and hydroxyzine hydrochloride. cetirizine or its salts when sold in concentration greater than 8.5 milligrams cetirizine per unit dose.	I	DEC / 13
Hyoscine and its salts and derivatives [scopolamine]	except Hyoscine butylbromide, when recommended for parenteral use	II	AUG / 16
Hyoscine butylbromide	When recommended for parenteral use.	I	AUG / 16
Hyoscyamine and its salts and derivatives	except for topical use	II	SEP / 98

40 result(s)

Print Friendly Export to CSV

Footnotes

C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR - Drug has not been reviewed by the NDSAC
PDL - Drug is listed in the Health Canada Prescription Drug List
TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act

National Drug Schedules

Search: National Drug Schedules

40 result(s)

Footnotes